{
    "nctId": "NCT02331212",
    "briefTitle": "Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer",
    "officialTitle": "Role of Hyaluronic Acid in Cancer Stem Cell Niche",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Carcinoma Metastatic to the Bone, Stage IV Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "HAS2 expression, measured by single-cell PCR",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients must have newly diagnosed, histologically confirmed primary and/or metastatic breast cancer\n* Ability to understand and the willingness to sign an Institutional Review Board (IRB)-approved informed consent document\n\nExclusion Criteria:\n\n* Patients who have had chemotherapy or radiotherapy",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT"
}